HAYWARD, Calif., Dec. 16, 2010 /PRNewswire/ -- Solta Medical, Inc. (Nasdaq: SLTM), the pioneer in fractional resurfacing and non-invasive skin tightening and a market leader in aesthetic skin treatments, today announced it has shipped its one millionth tip for the revolutionary Thermage and Fraxel devices that have helped to build the foundation of Solta Medical and transform the aesthetic medical device industry.
The milestone reflects how much the aesthetic medical device industry has changed in the past decade. The introduction of non-invasive devices like the Thermage's radiofrequency technology system in 2002 and Fraxel's fractional resurfacing laser in 2004 gave physicians popular, new options that provided patients effective results without the risks and downtime associated with surgery.
"The shipment of our millionth tip represents another important milestone for Solta Medical. With this achievement, Solta has demonstrated once again its leadership position in the market through the growing acceptance of our Thermage and Fraxel product lines," said Stephen J. Fanning, Chairman of the Board, president and CEO of Solta Medical, Inc. "We see other unmet needs in the aesthetic treatment continuum and we will continue to introduce new, safe, innovative anti-aging solutions to deliver the best possible results with non-invasive aesthetic treatments."
"Solta helped to transform aesthetic devices - with its deep roots in rigorous science - providing state-of-the-art technologies used to treat patients who sought effective, comfortable therapies," said Roy G. Geronemus, MD, Director of the Laser & Skin Surgery Center of New York. "There was a large patient base that sought more effective solutions than they could get from topical treatments but were either concerned about the cost or downtime associated with surgical procedures. Solta products have allowed me and my colleagues to make a meaningful difference in the lives of more patients by providing them with treatments that are both cost effective and efficacious."
As a result, many physicians have adopted Solta's innovative Thermage and Fraxel technologies to provide their patients state-of-the-art treatments, delivering natural-looking results without the risk associated with surgery. Today, more than 5,300 Thermage and Fraxel devices are being used to treat patients in more than 100 countries around the world.
To commemorate the company's growth and the success of the Thermage and Fraxel brands, Solta introduced its One in a Million campaign. The campaign celebrates Solta Medical's partnership with the loyal physicians around the globe who have helped to popularize these Solta products in particular and aesthetic technology in general. As part of the company's celebration, physicians in the US, Europe and Asia will be honored with a "practice makeover".
About the Thermage CPT system
The Thermage CPT system represents a leap forward in skin tightening and body contouring technology. The Thermage CPT incorporates proprietary Comfort Pulse Technology™, along with a breakthrough vibrating hand piece, to offer the maximum in treatment efficacy and patient comfort. Thermage is the premier non-invasive procedure to help tighten and contour skin in a single treatment with no surgery, no injections and little to no downtime.
About the Fraxel re:store Dual system
The new non-ablative Fraxel re:store Dual system takes the industry leading Fraxel technology to the next level by adding a novel 1927 nm wavelength, the first-ever application of a Thulium laser in the aesthetics market. The new wavelength enables physicians to treat multiple body areas in one treatment session and better address pigmentation and other dyschromia with minimal discomfort.
ABOUT SOLTA MEDICAL, INC.
Solta Medical, Inc. is a global leader in the medical aesthetics market providing innovative, safe, and effective solutions for patients that enhance and expand the practice of medical aesthetics for physicians. The company offers products to address a range of skin issues under the industry's four premier brands: Thermage®, Fraxel®, Isolaz®, and CLARO®. Thermage is an innovative, non-invasive radiofrequency procedure for tightening and contouring skin. As the leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin. Isolaz is the only laser or light based system indicated for the treatment of inflammatory acne, comedonal acne, pustular acne, and mild-to-moderate inflammatory acne. CLARO is a personal care acne system that is the only FDA cleared over-the-counter IPL device that uses a powerful combination of both heat and light to clear skin quickly and naturally. Since 2002, approximately one million Thermage, Fraxel and Isolaz procedures have been performed in over 100 countries. For more information about Solta Medical, call 1-877-782-2286 or log on to www.Solta.com.
© 2010 Solta Medical, Inc. All rights reserved. Thermage, Fraxel, Fraxel re:store, Isolaz and Solta Medical are trademarks or registered trademarks of Solta Medical, Inc. or its subsidiaries.
SOURCE Solta Medical, Inc.
Advertisement
The milestone reflects how much the aesthetic medical device industry has changed in the past decade. The introduction of non-invasive devices like the Thermage's radiofrequency technology system in 2002 and Fraxel's fractional resurfacing laser in 2004 gave physicians popular, new options that provided patients effective results without the risks and downtime associated with surgery.
Advertisement
"The shipment of our millionth tip represents another important milestone for Solta Medical. With this achievement, Solta has demonstrated once again its leadership position in the market through the growing acceptance of our Thermage and Fraxel product lines," said Stephen J. Fanning, Chairman of the Board, president and CEO of Solta Medical, Inc. "We see other unmet needs in the aesthetic treatment continuum and we will continue to introduce new, safe, innovative anti-aging solutions to deliver the best possible results with non-invasive aesthetic treatments."
"Solta helped to transform aesthetic devices - with its deep roots in rigorous science - providing state-of-the-art technologies used to treat patients who sought effective, comfortable therapies," said Roy G. Geronemus, MD, Director of the Laser & Skin Surgery Center of New York. "There was a large patient base that sought more effective solutions than they could get from topical treatments but were either concerned about the cost or downtime associated with surgical procedures. Solta products have allowed me and my colleagues to make a meaningful difference in the lives of more patients by providing them with treatments that are both cost effective and efficacious."
As a result, many physicians have adopted Solta's innovative Thermage and Fraxel technologies to provide their patients state-of-the-art treatments, delivering natural-looking results without the risk associated with surgery. Today, more than 5,300 Thermage and Fraxel devices are being used to treat patients in more than 100 countries around the world.
To commemorate the company's growth and the success of the Thermage and Fraxel brands, Solta introduced its One in a Million campaign. The campaign celebrates Solta Medical's partnership with the loyal physicians around the globe who have helped to popularize these Solta products in particular and aesthetic technology in general. As part of the company's celebration, physicians in the US, Europe and Asia will be honored with a "practice makeover".
About the Thermage CPT system
The Thermage CPT system represents a leap forward in skin tightening and body contouring technology. The Thermage CPT incorporates proprietary Comfort Pulse Technology™, along with a breakthrough vibrating hand piece, to offer the maximum in treatment efficacy and patient comfort. Thermage is the premier non-invasive procedure to help tighten and contour skin in a single treatment with no surgery, no injections and little to no downtime.
About the Fraxel re:store Dual system
The new non-ablative Fraxel re:store Dual system takes the industry leading Fraxel technology to the next level by adding a novel 1927 nm wavelength, the first-ever application of a Thulium laser in the aesthetics market. The new wavelength enables physicians to treat multiple body areas in one treatment session and better address pigmentation and other dyschromia with minimal discomfort.
ABOUT SOLTA MEDICAL, INC.
Solta Medical, Inc. is a global leader in the medical aesthetics market providing innovative, safe, and effective solutions for patients that enhance and expand the practice of medical aesthetics for physicians. The company offers products to address a range of skin issues under the industry's four premier brands: Thermage®, Fraxel®, Isolaz®, and CLARO®. Thermage is an innovative, non-invasive radiofrequency procedure for tightening and contouring skin. As the leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin. Isolaz is the only laser or light based system indicated for the treatment of inflammatory acne, comedonal acne, pustular acne, and mild-to-moderate inflammatory acne. CLARO is a personal care acne system that is the only FDA cleared over-the-counter IPL device that uses a powerful combination of both heat and light to clear skin quickly and naturally. Since 2002, approximately one million Thermage, Fraxel and Isolaz procedures have been performed in over 100 countries. For more information about Solta Medical, call 1-877-782-2286 or log on to www.Solta.com.
© 2010 Solta Medical, Inc. All rights reserved. Thermage, Fraxel, Fraxel re:store, Isolaz and Solta Medical are trademarks or registered trademarks of Solta Medical, Inc. or its subsidiaries.
SOURCE Solta Medical, Inc.
